99 related articles for article (PubMed ID: 8036749)
21. Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals.
Frost FJ; Tollestrup K; Craun GF; Fairley CK; Sinclair MI; Kunde TR
J Infect Dis; 2005 Aug; 192(4):618-21. PubMed ID: 16028130
[TBL] [Abstract][Full Text] [Related]
22. Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies.
McDonald V
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1077-86. PubMed ID: 22029525
[TBL] [Abstract][Full Text] [Related]
23. [Cryptosporidiosis].
Iseki M
Nihon Rinsho; 2003 Feb; 61 Suppl 2():608-12. PubMed ID: 12722289
[No Abstract] [Full Text] [Related]
24. Occurrence of bile-duct/duodenal abnormalities in nine AIDS patients co-infected with Cryptosporidium hominis and/or C. parvum.
Velásquez JN; di Risio C; Marta E; Astudillo OG; Etchart C; Cucher MA; Chertcoff AV; Perissé E; Carnevale S
Ann Trop Med Parasitol; 2010 Apr; 104(3):257-63. PubMed ID: 20507699
[No Abstract] [Full Text] [Related]
25. Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection.
Riggs MW; Schaefer DA; Kapil SJ; Barley-Maloney L; Perryman LE; McNeil MR
J Eukaryot Microbiol; 2001; Suppl():44S-46S. PubMed ID: 11906075
[No Abstract] [Full Text] [Related]
26. Comparison of Cryptosporidium parvum and Cryptosporidium wrairi by reactivity with monoclonal antibodies and ability to infect severe combined immunodeficient mice.
Chrisp CE; Mason P; Perryman LE
Infect Immun; 1995 Jan; 63(1):360-2. PubMed ID: 7806379
[TBL] [Abstract][Full Text] [Related]
27. [Studies on immunoprotection of monoclonal antibodies against Cryptosporidium parvum].
Zong H; Li W; Zhang X; Yu S; Bai B
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):101-5. PubMed ID: 12563792
[TBL] [Abstract][Full Text] [Related]
28. Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells.
Eichelberger MC; Suresh P; Rehg JE
Comp Med; 2000 Jun; 50(3):270-6. PubMed ID: 10894490
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing monoclonal antibody protects against Cryptosporidium parvum infection by inhibiting sporozoite attachment and invasion.
Langer RC; Riggs MW
J Eukaryot Microbiol; 1996; 43(5):76S-77S. PubMed ID: 8822871
[No Abstract] [Full Text] [Related]
30. Cases from the Osler Medical Service at Johns Hopkins University. Cryptosporidium parvum.
Nivatpumin P
Am J Med; 2004 Oct; 117(7):523-4. PubMed ID: 15464711
[No Abstract] [Full Text] [Related]
31. [Pancreatitis caused by Cryptosporidium parvum in patients with severe immunodeficiency related to HIV infection].
Calzetti C; Magnani G; Confalonieri D; Capelli A; Moneta S; Scognamiglio P; Fiaccadori F
Ann Ital Med Int; 1997; 12(2):63-6. PubMed ID: 9333315
[TBL] [Abstract][Full Text] [Related]
32. [Advances in researches on anti-Cryptosporidium parvum hyperimmune bovine colostrum].
Wang J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(2):119-22. PubMed ID: 12563798
[No Abstract] [Full Text] [Related]
33. Presence of heterogeneous copies of the small subunit rRNA gene in Cryptosporidium parvum human and marsupial genotypes and Cryptosporidium felis.
Xiao L; Limor JR; Li L; Morgan U; Thompson RC; Lal AA
J Eukaryot Microbiol; 1999; 46(5):44S-45S. PubMed ID: 10519242
[No Abstract] [Full Text] [Related]
34. Enzyme-linked immunosorbent assay for the detection of Cryptosporidium parvum IgG in the serum of cats.
Lappin MR; Ungar B; Brown-Hahn B; Cooper CM; Spilker M; Thrall MA; Hill SL; Cheney J; Taton-Allen G
J Parasitol; 1997 Oct; 83(5):957-60. PubMed ID: 9379309
[TBL] [Abstract][Full Text] [Related]
35. Risk of Cryptosporidium parvum transmission between hospital roommates.
Bruce BB; Blass MA; Blumberg HM; Lennox JL; del Rio C; Horsburgh CR
Clin Infect Dis; 2000 Oct; 31(4):947-50. PubMed ID: 11049775
[TBL] [Abstract][Full Text] [Related]
36. An immunocompetent rat model of infection with Cryptosporidium hominis and Cryptosporidium parvum.
Dayao DA; Sheoran A; Carvalho A; Xu H; Beamer G; Widmer G; Tzipori S
Int J Parasitol; 2020 Jan; 50(1):19-22. PubMed ID: 31759945
[TBL] [Abstract][Full Text] [Related]
37. Intestinal cryptosporidiosis as an initial manifestation in a previously healthy Japanese patient with AIDS.
Fujikawa H; Miyakawa H; Iguchi K; Nishizawa M; Moro K; Nagai K; Ishibashi M
J Gastroenterol; 2002; 37(10):840-3. PubMed ID: 12424568
[TBL] [Abstract][Full Text] [Related]
38. Involvement of host cell integrin α2 in Cryptosporidium parvum infection.
Zhang H; Guo F; Zhu G
Infect Immun; 2012 May; 80(5):1753-8. PubMed ID: 22354032
[TBL] [Abstract][Full Text] [Related]
39. Humoral antibody response and oocyst shedding after experimental infection of histocompatible newborn and weaned piglets with Cryptosporidium parvum.
Arnault I; Répérant JM; Naciri M
Vet Res; 1994; 25(4):371-83. PubMed ID: 8087146
[TBL] [Abstract][Full Text] [Related]
40. [Extreme hypercholesterolemia with xanthomatous eruptions caused by HIV-associated pericholangitis].
van Leusen R
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2232. PubMed ID: 10049097
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
